Terminology Service < Semantic Lookup Platform

All terms in HP

Label	Id	Description
Uniparental heterodisomy	HP_0032383	[A type of uniparental disomy in which the two different chromosomes (or chromosome segments) of the same parent are transmitted.]
epithelial cell of sweat gland	CL_1000448	[An epithelial cell that is part of the sweat gland.]
epidermal cell	CL_0000362	[An epithelial cell of the integument (the outer layer of an organism).]
epithelial cell of skin gland	CL_0002308	[An epithelial cell of a skin gland.]
negative regulation of cellular biosynthetic process	GO_0031327	[Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances, carried out by individual cells.]
kidney epithelial cell	CL_0002518	[An epithelial cell of the kidney.]
regulation of cellular biosynthetic process	GO_0031326	[Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances, carried out by individual cells.]
Isoleucinuria	HP_0032371	[An increased concentration of isoleucine in the urine.]
negative regulation of leukocyte chemotaxis	GO_0002689	[Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte chemotaxis.]
negative regulation of chemotaxis	GO_0050922	[Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.]
Blood group A	HP_0032370	[ABO phenotype A, corresponding to the genotype AO or AA.]
regulation of chemotaxis	GO_0050920	[Any process that modulates the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.]
positive regulation of cell migration	GO_0030335	[Any process that activates or increases the frequency, rate or extent of cell migration.]
negative regulation of cell migration	GO_0030336	[Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.]
regulation of cell migration	GO_0030334	[Any process that modulates the frequency, rate or extent of cell migration.]
immune system process	GO_0002376	[Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.]
Polymorphous light eruption	HP_0032379	[The cardinal symptom is severely pruritic skin lesions. Macular, papular, papulovesicular, urticarial, multiforme- and plaque-like variants are differentiated morphologically, hence the name polymorphous. Usually one morphology dominates in a single individual (monomorphous). The skin lesions develop a few hours to several days after sun exposure. Initially, patchy erythema develops, accompanied by pruritus. Distinct lesions then develop. The upper chest, upper arms, backs of the hands, thighs, and the sides of the face are the primary localizations. The skin lesions resolve spontaneously within several days of ceasing sun exposure and do not leave behind any traces.]
diol	CHEBI_23824	[A compound that contains two hydroxy groups, generally assumed to be, but not necessarily, alcoholic. Aliphatic diols are also called glycols.]
Immediate-type hypersensitivity drug reaction	HP_0032378	[Hypersensitivity that is observed within 1 hr of exposures. A variety of adverse reactions can occur within minutes to hours of exposure to a drug. Some can be related to the pharmacological action of the drug (WHO Adverse Reaction Terminology type A for augmented) and usually have a low mortality. Others are not readily predictable based on the structure and pharmacological action of the drug and have a relatively high mortality risk (Type B for bizarre). The most serious form of immediate onset drug hypersensitivity reaction, anaphylaxis. Other reactions including itching,dizziness/light-headedness, nausea, chest discomfort but without any objective skin features, physical signs or physiological compromise. Skin only reactions include generalized erythema, urticaria or angioedema without any sentinel features (see below) of other organ involvement.]
Increased urinary orosomucoid	HP_0032377	[An increased concentration in the urine of alpha-1-acid glycoprotein (AGP), also known as orosomucoid (ORM). AGP is a 41-43-kDa glycoprotein with a pI of 2.8-3.8. AGP is an acute-phase protein that has many activities including, but not limited to, acting as an acute-phase reactant and disease marker, modulating immunity, binding and carrying drugs, maintaining the barrier function of capillary, and mediating the sphingolipid metabolism.]